about
Transsulfuration pathway thiols and methylated arginines: the Hunter Community StudyProton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General PopulationPlasma levels of asymmetric dimethylarginine in patients with biopsy-proven nonalcoholic fatty liver disease.Left ventricular diastolic dysfunction and plasma asymmetric dimethylarginine concentration in persons with essential hypertensionL-arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure.Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance.Chronic diet-induced hyperhomocysteinemia impairs eNOS regulation in mouse mesenteric arteries.How May Proton Pump Inhibitors Impair Cardiovascular Health?Regular cigarette smoking influences the transsulfuration pathway, endothelial function, and inflammation biomarkers in a sex-gender specific manner in healthy young humans.Demethylation treatment restores erectile function in a rat model of hyperhomocysteinemiaDimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study.The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.Association between gastroesophageal reflux disease and coronary heart disease: A nationwide population-based analysis.ADMA and SDMA levels in healthy men exposed to tobacco smoke.Hyperhomocysteinemia and Endothelial Dysfunction.Associations between asymmetric dimethylarginine, homocysteine, and the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism (rs1801133) in rheumatoid arthritis.Cellular hypomethylation is associated with impaired nitric oxide production by cultured human endothelial cells.Inhibition of human dimethylarginine dimethylaminohydrolase-1 by S-nitroso-L-homocysteine and hydrogen peroxide. Analysis, quantification, and implications for hyperhomocysteinemia.The metabolism and significance of homocysteine in nutrition and health.Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets.Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis.Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.
P2860
Q28485286-E1E71451-C4E5-45A2-AE34-B5A2DF2FC570Q28548045-ADDA6FCE-4E23-440D-95CE-8A2CCD3DF572Q34448584-668F668C-0E75-494E-9E3E-98D27776AF89Q35829220-279B111E-13D8-44BF-BB37-ACCF6408084DQ35961528-2CFC3B15-07D0-4B50-87AC-692612DE5228Q36273357-C86E6D5A-0751-4FE5-83EC-15EB6A2E26E2Q36808089-6BA11685-ED18-4BF5-BAE0-164EE967A4B6Q36892867-D07C5799-9C60-41C7-9EEF-D8F0DB5185D2Q37099894-FA088F90-1739-4C2B-974E-ACE68919B2B2Q37210355-79E6FCDE-CF9B-456E-8909-8EDEA6138EDDQ37290635-C595D0DF-7D35-4E38-9FFE-2FA74F301069Q37313734-BBA7DB40-2DDF-4CC0-B149-5F99D2E59901Q37328036-9849DDEC-C63B-4190-AECD-548231C97866Q37462898-0F5BC363-CE4B-4ADC-923F-AFB2062A1F47Q37760050-52F44DFB-51F6-46D8-8A21-3560F01E5FF8Q41102153-B168FCD1-50AA-4D49-AA26-F5304468B6B7Q41973706-8540AC50-7965-45AC-9EA1-065E18EA493DQ46982143-64EE0E08-5A4E-4ECC-9D71-4299092F8047Q47144280-21366576-23EC-407F-9F04-9CDBE979E52EQ47912637-430FFF03-81F7-427A-8A40-2C5861AD67B5Q52632609-5713C2A8-2BFC-452E-A4AC-060E131F18DBQ55107043-A6BA30D1-88FA-4D36-B610-85BE9F232E10
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
ADMA and hyperhomocysteinemia
@ast
ADMA and hyperhomocysteinemia
@en
ADMA and hyperhomocysteinemia
@nl
type
label
ADMA and hyperhomocysteinemia
@ast
ADMA and hyperhomocysteinemia
@en
ADMA and hyperhomocysteinemia
@nl
prefLabel
ADMA and hyperhomocysteinemia
@ast
ADMA and hyperhomocysteinemia
@en
ADMA and hyperhomocysteinemia
@nl
P3181
P1433
P1476
ADMA and hyperhomocysteinemia
@en
P2093
Sanjana Dayal
Steven R Lentz
P304
P3181
P356
10.1191/1358863X05VM599OA
P407
P478
10 Suppl 1
P577
2005-07-01T00:00:00Z